HealthcareServices

Decentralized Clinical Trials Market to Grow at a CAGR of 17.5% from 2025 to 2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Decentralized Clinical Trials Market Covering 2025–2034?

The decentralized clinical trials market size has experienced significant expansion in recent years. It is projected to expand from $7.44 billion in 2024 to $8.77 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.8%. This historical growth can be attributed to several factors, including the increasing integration of electronic data capture systems, the rising prevalence of wearable health monitoring devices, enhanced regulatory encouragement for patient-centric trials, a greater need for cost-effective trial frameworks, and the broader deployment of remote monitoring solutions.

The decentralized clinical trials market is poised for substantial expansion over the next few years, with projections indicating it will reach $16.68 billion by 2029, growing at a compound annual growth rate (CAGR) of 17.5%. This anticipated growth is fueled by several factors, including the incorporation of artificial intelligence and machine learning in trials, the increasing implementation of blockchain for data security, the rising prevalence of rare and chronic diseases which necessitate decentralized models, the expanding use of real-world evidence in trial design, and the broader availability of 5G connectivity to support seamless trial operations. Additionally, key trends for the forecast period encompass the integration of artificial intelligence and machine learning, the adoption of wearable and biosensor technologies, a greater reliance on telemedicine and remote monitoring, the enhancement of data security and transparency through blockchain, and the development of cloud-based clinical trial management platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28189&type=smp

Which Major Market Drivers Are Shaping The Future Of The Decentralized Clinical Trials Market?

The increasing emphasis on telemedicine is projected to stimulate expansion in the decentralized clinical trials market in the future. Telemedicine involves providing medical services from a distance using digital communication tools, allowing for health consultations and supervision without the need for patients to be physically present at medical centers. This heightened attention on telemedicine is largely due to the demand for easily accessible healthcare, especially given global health crises and the necessity for social distancing. Decentralized clinical trials leverage telemedicine to remotely interact with and oversee patients, thereby reducing face-to-face appointments while facilitating immediate data gathering, enhanced accessibility, and uninterrupted supervision. For example, in August 2023, Vivalink, a US-based healthcare technology firm, reported that 81% of clinicians currently utilize remote patient monitoring (RPM), a substantial increase from only 20% in 2021, marking a 305% surge. Additionally, 84% of existing RPM users plan to broaden their application of this technology during 2024. Consequently, the increased emphasis on telemedicine is fueling the expansion of the decentralized clinical trials market.

What Are The Major Segment Categories Driving The Decentralized Clinical Trials Market Growth?

The decentralized clinical trials market covered in this report is segmented as

1) By Type: Interventional, Observational, Expanded Access

2) By Technology Used: Wearable Devices, Mobile Health Applications, Telemedicine Platforms, Electronic Data Capture Systems

3) By Study Phase: Phase I, Phase II, Phase III, Phase IV

4) By Therapeutic Area: Oncology, Cardiology, Neurology, Infectious Diseases

5) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations, Regulatory Authorities, Academic And Research Institutions

Subsegments:

1) By Interventional: Randomized Controlled Trials (RCTs), Non-Randomized Trials, Adaptive Clinical Trials, Pragmatic Clinical Trials

2) By Observational: Cohort Studies, Case-Control Studies, Cross-Sectional Studies, Prospective Studies, Retrospective Studies, Longitudinal Studies

3) By Expanded Access: Treatment Investigational New Drug (IND) Applications, Intermediate-Size Patient Population Investigational New Drug (IND) Applications, Single-Patient Investigational New Drug (IND) Applications, Emergency Use Investigational New Drug (IND) Applications

How Are Trends Influencing The Decentralized Clinical Trials Market?

Leading companies in the decentralized clinical trials market are concentrating on developing advanced solutions, such as integrated, no-code clinical trials software, to streamline trial setup and management, thereby enhancing overall efficiency and patient engagement. This type of all-in-one, no-code clinical trials software empowers researchers to design, manage, and conduct trials without requiring coding expertise, seamlessly integrating patient recruitment, data capture, monitoring, and analytics into a single user-friendly platform. For example, in August 2024, Medable, a US-based clinical technology company, launched Medable Studio, a comprehensive, no-code software solution engineered to simplify and accelerate the configuration, translation, validation, and deployment of electronic Clinical Outcome Assessments (eCOA), eConsent, Televisit, and sensors Plus into clinical trials. This innovation enables biopharmaceutical companies to create protocol-compliant study designs in hours rather than months, affording users greater control, transparency, and speed, while offering flexible self-service, full-service, or hybrid options that significantly reduce study startup timelines and costs. The platform’s objective is to revolutionize trial execution by making the study build process faster, more efficient, and less dependent on professional services.

Who Are The Major Companies Operating In The Decentralized Clinical Trials Market?

Major companies operating in the decentralized clinical trials market are Walgreens Boots Alliance Inc., Pfizer Inc., Oracle Corporation, Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Labcorp Holdings Inc., ICON Public Limited Company, Dassault Systèmes SE, LEO Pharma A/S, Verily Life Sciences LLC, ProPharma, Signant Health Holding Corp., PCM Trials, Huma Therapeutics Limited, Medable Inc., Science 37 Inc., Obvio Health, EmVenio Research Inc., Grove AI Inc., Phesi Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/decentralized-clinical-trials-global-market-report

How Does The Decentralized Clinical Trials Market Perform Across Key Geographic Regions?

North America was the largest region in the decentralized clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in decentralized clinical trials report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Decentralized Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28189&type=smp

Browse Through More Reports Similar to the Global Decentralized Clinical Trials Market 2025, By The Business Research Company

Healthcare Data Annotation Tools Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-data-annotation-tools-global-market-report

Healthcare Data Integration Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-data-integration-global-market-report

Personal Health Record Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795